The nonstructural region of the genome of the avirulent A7 strain of Semliki Forest virus (SFV) has been sequenced, so that the complete nucleotide sequence is available. Compared to the virulent SFV4 strain (produced from the infectious clone pSP6-SFV4), A7 contains 226 nucleotide changes in the translated region, which result in 47 amino acid changes. The 5h nontranslated region has two nucleotide changes, and the 3h nontranslated region is longer in A7 than SFV4, and contains divergent
Introduction
Infectious clones to enable the molecular analysis of pathogenesis of alphaviruses have been constructed for Sindbis virus, Venezuelan equine encephalitis (VEE) virus and Semliki Forest virus (SFV). Studies on VEE virus have been aimed at identifying attenuating sequences, which are located mainly in the E2 envelope glycoprotein gene and in the 5h nontranslated region (Davis et al., 1991 ; Kinney et al., 1993) . Virus produced from the original infectious clone of Sindbis virus was virulent only for neonatal mice (Lustig et al., 1988 ; Polo et al., 1988) . The use of monoclonal antibody escape mutants in analysis of Sindbis virus virulence led to the generation of mutations in the envelope protein region (Pence et al., 1990) . Changes in both the E1 and E2 proteins reduce virulence, and a gradient of virulence exists involving changes in both proteins (Lustig et al., 1988 ; Polo & Johnston, 1990) . A pathogenesis domain present in the E2 protein has been defined using both monoclonal antibodies and site-directed mutagenesis of the infectious clone (Pence et al., 1990 ; Polo & Johnston, 1991 ; Schoepp & Johnston, 1993) . It has also been shown for a neuroadapted strain of Sindbis virus that virulence for weanling mice is controlled by a single amino acid change in the E2 Author for correspondence : Gregory J. Atkins.
Fax j353 1 6799294. e-mail gatkins!tcd.ie and repeated sequences. Chimeras containing SFV4 and A7 sequences and an infectious clone of A7, pSP6-CA7, were constructed. The virulence of these was tested by intraperitoneal and intranasal infection of adult BALB/c mice. It was shown that determination of the avirulent phenotype of A7 was polygenic, and required the additive effect of sequences from both the structural and nonstructural regions of the SFV genome.
protein (Tucker et al., 1993) , and this was confirmed for other neuroadapted strains isolated from SCID mice (Levine & Griffin, 1993) .
SFV differs from Sindbis virus in having a greater range of pathogenicity for the central nervous system (CNS) and foetus (Atkins et al., 1985 (Atkins et al., , 1994 (Atkins et al., , 1995 . Virulent strains such as the prototype strain or the L10 strain cause a lethal threshold of damage to neurons in the CNS (Atkins & Sheahan, 1982 ; Atkins et al., 1990 ; Smyth et al., 1990 ; Glasgow et al., 1991 ; Balluz et al., 1993) . Avirulent strains or mutants such as A7 and M9 are less cytopathic for neurons (Atkins et al., 1985 (Atkins et al., , 1995 Fazakerley et al., 1993) and induce demyelination which is triggered by infection of oligodendrocytes (Atkins et al., 1985 (Atkins et al., , 1994 and is partially immune-mediated (Gates et al., 1984 ; Fazakerley & Webb, 1987 ; Subak-Sharpe et al., 1993) .
To study the molecular basis of SFV pathogenesis, the infectious clone pSP6-SFV4 has been utilized (see Fig. 1 ; Liljestro$ m et al., 1991 ; Glasgow et al., 1991 Glasgow et al., , 1994 Santagati et al., 1995) . This clone was constructed from the prototype strain of SFV of known sequence (Garoff et al., 1980 a, b ; Takkinen, 1986) . On transcription and electroporation into BHK cells it produces SFV4 virus, which is virulent when given intranasally (Glasgow et al., 1991) . In order to identify pathogenicity determinants of the A7 strain of SFV, we sequenced the envelope protein region and showed that A7 differed from SFV4 in amino acid sequence. The 3h non-translated region was longer than that of SFV4 and contained repeated elements (Glasgow et al., 1994) . Similar results were obtained by Santagati et al. (1994) , who also showed that a chimera containing most of the E2 region from A7 and the remainder of the genome from SFV4 was attenuated (Santagati et al., 1995) .
Here we present the sequence of the nonstructural region of A7-SFV, so the complete sequence is now available. We also show that determination of the avirulent phenotype of A7 is polygenic, and requires the additive effect of sequences from both the structural and nonstructural regions of the SFV genome.
Methods
Virus. Growth and assay of the avirulent A7 strain of SFV in BHK-21 cells was as previously described (Balluz et al., 1993) . The virulent SFV4 strain of SFV was produced by transcription and electroporation of the pSP6-SFV4 infectious clone of SFV (Glasgow et al., 1991) . In infection experiments, 6-week-old BALB\c mice were given 10' p.f.u. of virus intranasally (i.n.) or intraperitoneally (i.p. ; Balluz et al., 1993) . To verify infection, all surviving mice were challenged with a normally lethal dose of 10' p.f.u. of the virulent L10 strain of SFV given i.p. Virulence was assessed by the ability of administered virus to kill mice ; mortality was measured by the number of mice killed and their mean time of death following infection. Significance was assessed at the 5 % level ; the Fisher exact test was used for proportion of mice killed and Student's t-test for time of death. The neuropathology of mice infected i.n. was examined as previously described (Sheahan et al., 1996) .
Sequencing. A7-SFV was grown in BHK cells and virion RNA was prepared by discontinuous density gradient centrifugation, polyethylene glycol precipitation, phenol-chloroform extraction and ethanol precipitation (Atkins & Sheahan, 1982) . Reverse transcription of this RNA was carried out using a first strand cDNA synthesis kit (Pharmacia) and custom primers from the sequence of the SFV4 strain of SFV. cDNA was amplified by PCR (30 cycles) in 500 bp fragments. Primers for PCR were synthesized from the SFV4 sequence and contained a 20-mer virusspecific sequence with added restriction sites at the 5h end to facilitate cloning. Each 500 bp fragment overlapped the last so that the PCR primer sites were contained in overlapping regions. DNA fragments obtained from PCR were purified using the Geneclean system (Bio 101) and digested with the appropriate restriction enzyme so that the fragment contained the necessary sticky ends for ligation into plasmid pUC19. Such constructs were transformed into E. coli strain XL and clones containing inserts selected by blue\white screening. Plasmid DNA was purified with the Wizard Mini-prep kit (Promega) and cycle sequenced by the automated Sanger dideoxy method using dye-labelled universal forward and reverse primers and an ABI 373A automated DNA sequencer. Both strands of the DNA and three independent clones of each 500 bp fragment were sequenced to avoid cloning artefacts. Where amino acid changes were detected in the A7 sequence compared to SFV4, these were confirmed by sequencing the appropriate region of the pSP6-SFV4 plasmid DNA.
Nomenclature of chimeras. Chimeras are labelled according to the position of the A7 fragment inserted into the pSP6-SFV4 plasmid : e.g. chimera C276\2571 contains an A7 insert from nucleotides 276 to 2571 of the virus genome ; the plasmid from which chimeric RNA is transcribed is labelled P276\2571. For simplicity, the complete A7 infectious clone is labelled pSP6-CA7 and the virus derived from it CA7.
Nonstructural region chimeras all contain the 6714\7783 A7 sequence (see below), but this is omitted from labels for brevity except where this sequence is continuous with another inserted A7 fragment.
Construction of chimeric virus. Construction of chimeras was carried out using the restriction enzyme sites on the pSP6-SFV4 plasmid shown in Fig. 1 . In all cases, the presence of the intended sequences in recombinant plasmids was verified by the presence of restriction enzyme sites specific to the A7 sequence, or by sequencing. The presence of the intended sequences in chimeric viruses was verified in the same way by extraction of RNA from infected cells followed by RT-PCR. In initial screening of recombinant plasmids, use was made of the larger 3h nontranslated region in A7, which could be detected by PCR, the absence of AflII 7123, SnaBI 952 and EcoRI 8744 restriction sites and the presence of the SpeI 9052 site in the A7 sequence. In all cases, chimeric plasmids were constructed using DNA from plasmids with large deletions as source material.
Two sources of A7 sequences were used in the construction of chimeras ; one was a cDNA clone of the A7 structural sequence (Glasgow et al., 1994) . The other was by RT-PCR, i.e. using PCR-amplified cDNA made from A7-infected cell extracts. RNA was extracted using RNAgents denaturing buffer (Promega), then phenol-chloroform extracted, precipitated with an equal volume of isopropanol, washed with 70 % ethanol and resuspended in RNase-free water. For production of virus from infectious clones, the plasmid was linearized with SpeI, then transcribed using SP6 polymerase and the RNA electroporated into BHK cells, as previously described (Glasgow et al., 1991) . Sequence analysis showed that A7 had a SpeI site at position 9052 which was absent in SFV4. However, partial digestion with SpeI allowed infectious virus to be recovered from such constructs. Virus produced by electroporation was used to reinfect BHK cells, and the resultant virus stock was titrated and stored in aliquots at k70 mC before testing in mice.
Construction of structural region chimeras. As a preliminary step, plasmid P∆8930\11033 was constructed by deletion of the pSP6-SFV4 plasmid between the two NdeI restriction sites, and subsequent ligation of the deleted plasmid. This deleted plasmid was transformed into E. coli XL and plasmid DNA prepared. To construct P11034\11515, a PCR amplimer was first prepared by RT-PCR using a primer upstream of the NdeI 11033 site, and a downstream primer corresponding in sequence to the 3h end of the virus genome plus an added 5h SpeI restriction site. The SpeI 11515 to NdeI 11033 fragment was deleted from P∆8930\11033, and the PCR amplimer inserted by ligation. The 8930\11033 fragment from SP6-SFV4 was then inserted, and the orientation checked by sequence analysis. A plasmid containing this sequence in the correct orientation was selected for subsequent analysis. To construct P8930\11033, the 8930\11033 fragment was excised from the A7 structural sequence clone, and ligated into P∆8930\11033. As two orientations were possible, recombinant plasmids were screened by sequencing, and a plasmid containing the insert in the correct orientation was selected for further analysis. To construct P7784\8929, a PCR amplimer was made by RT-PCR using primers located on either side of the NdeI 8929 and SfuI 7783 sites. This was ligated into P∆8930\11033 after deletion of the corresponding fragment. The 8930\11033 fragment from SP6-SFV4 was then ligated into the NdeI site, and a clone of the correct orientation selected for further analysis. To construct P6714\ 7783, the region between the BglII 6713 and SfuI 7783 sites was removed from pSP6-SFV4, the corresponding region of A7 generated by RT-PCR, and the A7 fragment inserted by ligation. The plasmid P6714\11515, which contained the complete 3h structural sequence from A7, including the nontranslated region, was constructed using P11034\11515 and inserting additional A7 sequences as described above.
Sequence analysis of SFV Sequence analysis of SFV 
Construction of nonstructural region chimeras.
To construct nonstructural region chimeras, the plasmid P6714\7783 was used as a basis for further constructs. Preliminary experiments showed that chimeric virus from this plasmid had only slightly reduced virulence (see Table 2 ). The advantage of using P6714\7783 is that it is deficient in the AflII 7123 site compared to pSP6-SFV4 due to the presence of the A7 insert. As a preliminary step, plasmid P∆2572\3914 was constructed by deletion of the pSP6-SFV4 plasmid between the two AflII restriction sites present in P6714\7783, and subsequent ligation of the deleted plasmid. To construct P3915\7783, the A7 sequence was inserted into P∆2572\ 3914 in two stages. First, the A7 fragment BglII 6713-NotI 6145 was generated by RT-PCR using a primer incorporating a AflII site at the 5h end to provide the necessary ligation site. This was inserted into P∆2572\3914 between the AflII and BglII sites after removal of the corresponding region. The second stage was the insertion of the A7 fragment from AflII 3914 to NotI 6145. To complete the clone P3915\7783, the AflII 2572\3914 sequence from pSP6-SFV4 was inserted in the correct orientation. P2572\3914 was constructed by generation of the appropriate A7 fragment by RT-PCR and insertion of this fragment in the correct orientation into the AflII site of P∆2572\3914. To construct P276\2571, a double deletion plasmid was first constructed by deletion of the NdeI fragment 8930\11033 from P∆2572\3914. This was carried out to remove the EcoRV 9554 site. The deleted plasmid therefore had a unique EcoRV 275 site, and the EcoRV 275-AflII 2571 sequence was removed and the corresponding A7 sequence inserted from an RT-PCR amplimer. To complete the clone, both the NdeI 8930\11033 and AflII 2572\3914 sequences were replaced in the correct orientation from pSP6-SFV4. To construct P276\7783, the A7 sequence was generated as a single fragment rather than in stages, to reduce the possibility of cloning artefacts. The Expand PCR system was used (Boehringer), according to the manufacturer's protocol. This was used to generate the complete 6n5 kb A7 fragment, which was inserted into the double deletion plasmid described above between the EcoRV 275 and BglII 6713 sites. To complete the construct, the NdeI 8930\11033 fragment was replaced from pSP6-SFV4 in the correct orientation to give a chimera containing the complete nonstructural region from A7.
Construction of the A7 translated region chimera.
To construct P276\11515, which contains the complete translated and 3h nontranslated region from A7, the A7 sequence from P6714\11515 was inserted into P276\7783. A deletion was first made in P6714\11515 between the NdeI 8929 and 11033 sites, and the deleted plasmid ligated and transformed into E. coli XL for preparation of plasmid DNA. The region BglII 6713\SpeI 11515 was removed from this deleted plasmid DNA to act as an insert into P276\7783. To complete the construct, the A7 NdeI 8930\11033 fragment was replaced in the correct orientation.
Construction of the A7 infectious clone. This was carried out by site-directed mutagenesis of the 5h nontranslated region of P276\ 11515, to change the T at position 35 and the C at position 42 in the SFV4 sequence, to A and T in the A7 sequence. First, the region between EcoRV 275 and EcoRV 9554 was removed and ligated to produce a deletion plasmid. This was mutated using the Stratagene Quikchange site-directed mutagenesis kit according to the manufacturer's instructions. The oligonucleotides used for mutagenesis were 5h CGCCAAAA-GAATTTGTTTCAGCTCCTGCC, which incorporates both nucleotide changes (underlined), and its complementary sequence. The presence of the required mutations was confirmed by sequencing, and the region between SpeI 11515 and EcoRV 275 of the mutated clone removed to act as an insert into the appropriate region of P276\11515, to give pSP6-CA7.
Results and Discussion

Sequence of A7-SFV
Compared to SFV4, the complete genome sequence of A7-SFV has 226 nucleotide changes (98n2 % identity) and 47 amino acid changes (98n7 % identity) in the translated region (Table  1 ). It has previously been shown that the 3h nontranslated region is longer for A7 than SFV4 and contains repeated and divergent elements (Glasgow et al., 1994 ; Santagati et al., 1994) . The 5h nontranslated region has two nucleotide changes, whereas the nontranslated junction region between the (794) C\S (237) T\C (1007) Y\H (308) A\G (1244) I\V (387) T\C (1536) V\A (484) G\T (1650), A\G (1651) G\V (522) A\G (1686) H\R (534) nsP2 C\A (2021) H\N (109) G\A (2120) V\I (142) A\T (2193) Y\F (166) C\A (2472) S\Y (259) C\T (2787) A\V (365) C\A (2879), A\T(2880), G\A (2881) Q\I (395) T\A (3240) V\E (515) G\A (3359) G\R (555) C\A (3428) Q\K (578) A\T (3466) R\S (590) C\T (3660) S\L (655) C\A (3675) T\K (660) A\T (3693) Y\F (666) G\C (3730) R\S (678) C\A (3733) F\L (679) G\A (3856) N\S (721) nsP3 C\G (4299), G\C (4300) A\G(70) T\A (4343) L\M (85) G\C (5368) E\D (426) C\A (5372) P\T ( (8291) V\A (24) E2 G\A (8427) V\I (37) A\C (8729) K\T (104) A\G (8902) ‡ K\E (162) ‡ A\G (9053) N\S (212) T\C (9518) V\A (367) T\C (9530) V\A (371) T\C (9584) V\A (389) E1 G\T (10057) A\S (65) G\A (10208) R\K (115) T\C (10547) M\T (228) T\C (10754) I\T (297) C\A (10820) T\K (329) A\G (10841) N\D (333) G\A (10982) R\K (373) * Nucleotides are numbered from the start of the SFV4 sequence. † Amino acids are numbered from the start of the appropriate SFV4 protein.
BFFD
‡ This represents a change from the sequence of SFV4 but not from the sequence of the prototype strain (Glasgow et al., 1994) . nonstructural and structural region of the genome has no nucleotide changes. There is a larger number of amino acid changes in the nsP2 gene than in other genes. The structural region translated sequence which we have determined for A7-SFV (Glasgow et al., 1994 ; Table 1 ) is identical to that determined by Santagati et al. (1994 Santagati et al. ( , 1995 , except for one amino acid change (T\K at position 329 in the E1 protein).
BFFE
Virulence of chimeric viruses
The virulence of chimeric viruses compared to SFV4 and A7 is shown in Table 2 , and a diagram of the location and extent of A7 sequences in chimeras is shown in Fig. 2 . When administered by the i.n. or i.p. route, the CA7 virus produced from the pSP6-CA7 infectious clone, like A7, caused no mortality, but inflammatory demyelination with some neuronal necrosis was present in the CNS of 6 mice examined at 14 days after i.n. infection. These lesions were qualitatively similar to those described for A7 (Sheahan et al., 1996) . Chimeras containing larger A7 inserts were generally more attenuated than those containing smaller inserts. The chimera C276\ 11515 containing the translated region from A7, with only the 5h nontranslated region from SFV4, was most attenuated but killed 2 out of 25 mice when administered i.n. Lesions induced in the CNS of 6 mice infected i.n. by this chimera were also more severe 14 days after infection than those induced by A7. These results indicate that this chimera retained a small degree of virulence. This may be due to the two nucleotide changes in the 5h nontranslated region, since site-directed mutagenesis of these to produce the complete A7 infectious clone resulted in full attenuation. Such a mutation in the 5h nontranslated region has been shown to influence virulence for VEE, in combination with a mutation in the E2 gene (Kinney et al., 1993) . Although the 3h nontranslated region of A7 differs in sequence from that of SFV4 (Glasgow et al., 1994 ; Santagati et al., 1994) , it plays no role in the determination BFFF of neurovirulence, as shown by the result obtained for the chimera C11034\11515 (Table 2) .
We have previously shown that amino acid substitutions in the E2 protein result in attenuation (Glasgow et al., 1991 (Glasgow et al., , 1994 . Also, Santagati et al. (1995) have shown that a chimeric virus containing six of the seven amino acid substitutions of the E2 protein, present in A7 compared to SFV4, is attenuated. Our results show that the C8930\11033 chimera, which contains all the amino acid substitutions of the E1 gene, and four of the seven amino acid substitutions of the E2 gene, is significantly attenuated. Taken together, these results indicate that the envelope region is a major virulence determinant. It is also clear, however, that the determinants of virulence in the SFV genome are multiple, since chimeras consisting of the complete structural sequence from one strain and the complete nonstructural sequence from the other, in both combinations (C276\7783 and C6714\11515), are more attenuated than chimeras containing smaller fragments. Thus, attenuating mutations are present throughout the genome and exert an additive effect to produce the full attenuated A7 phenotype.
The other alphaviruses which have been investigated by chimeric virus construction are Sindbis virus and VEE virus. For both these viruses, the E2 gene has been shown to be a major pathogenicity determinant (Lustig et al., 1988 ; Polo et al., 1988 ; Pence et al., 1990 ; Polo & Johnston, 1990 Davis et al., 1991 ; Kinney et al., 1993 ; Levine & Griffin, 1993 ; Schoepp & Johnston, 1993 ; Tucker et al., 1993 ; Ubol et al., 1994) , but so far no nonstructural protein genes have been implicated. For SFV, the nonstructural as well as the structural genes are pathogenicity determinants, and attenuating mutations for the A7 strain are multiple and additive.
The i.n. route of infection has been used in this study because it is a more direct route for infection of the CNS and results in a less variable response than i.p. infection (Sheahan et al., 1996) . However, because i.p. infection has been used in many previous studies (Atkins et al., 1985 (Atkins et al., , 1994 , we have also used this route of infection. Although the i.n. route is a more sensitive indicator of neurovirulence, there is no qualitative difference in the results obtained for the two routes of infection (Table 2) .
It is clear from other studies that the major functional difference between A7 and SFV4 which determines neurovirulence is ability to multiply in neurons. The multiplication of A7 is restricted in neurons, both in cell culture (Atkins, 1983 ; Gates et al., 1985 ; Atkins et al., 1990) and in the animal (Balluz et al., 1993 ; Fazakerley et al., 1993) . However, this restriction is not due to less efficient multiplication of A7 per se, since A7 multiplies at least as efficiently as SFV4 in some cells, such as BHK cells and glial cells (Atkins, 1983 ; Atkins et al., 1990) . It is possible that the sequences which control neurovirulence for SFV may be manifested at the cellular level in the ability of the virus to multiply in neurons and hence cause lethal neuronal damage.
